Core Insights - The article emphasizes that the development of the biomanufacturing industry in China is not merely a "shortcut" but a strategic choice to disrupt traditional industrial systems through technological innovation [2][3] - Biomanufacturing is recognized as a key driver for China's economic growth and sustainable development, with significant government support and policy initiatives [2][3] Industry Overview - The total scale of China's biomanufacturing industry is approaching 1 trillion yuan, with predictions that it will grow to 1.8 trillion yuan by 2030, capturing nearly 25% of the global market [3] - Biomanufacturing encompasses various sectors, including healthcare, industrial chemicals, food supplements, and bioenergy [3] Technological Advancements - Over the past five years, China has filed over 120,000 biomanufacturing-related patents, accounting for 39.5% of the historical total [3] - The industry faces challenges in overcoming technological, model, and institutional bottlenecks, necessitating advancements in AI and automation to improve efficiency [4][5] Industry Structure and Upgrades - The biomanufacturing process involves multiple stages, including cell selection, fermentation optimization, and quality control, with a diverse range of supporting and technical enterprises [6] - Domestic bioreactor market share has increased from below 30% to over 50%, although key sensors and software still rely on imports [6][7] Future Trends - Biomanufacturing is expected to replace traditional chemical methods in various applications, including biodegradable plastics and pharmaceuticals [8] - The industry is poised for significant advancements in drug synthesis and environmental sustainability, with a focus on reducing carbon emissions and improving waste management [8][9]